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Abstract
Purpose This study examined the effectiveness, feasibility,
and satisfaction with implementation of the FOCUS program
in two US Cancer Support Community affiliates in Ohio and
California as well as the cost to deliver the program. FOCUS
is an evidence-based psychoeducational intervention for
dyads (cancer patients and caregivers).
Methods A pre-post-intervention design was employed.
Eleven, five-session Focus programs were delivered by li-
censed professionals in a small group format (three–four
dyads/group) to 36 pat ient-caregiver dyads . An
Implementation Training Manual, a FOCUS Intervention
Protocol Manual, and weekly conference calls were used to
foster implementation. Participants completed questionnaires
prior to and following completion of each five-session
FOCUS program to measure primary (emotional distress,
quality of life) and secondary outcomes (benefits of illness,
self-efficacy, and dyadic communication). Enrollment and re-
tention rates and fidelity to FOCUS were used to measure
feasibility. Cost estimates were based on time and median
hourly wages. Repeated analysis of variance was used to an-
alyze the effect of FOCUS on outcomes for dyads. Descriptive
statistics were used to examine feasibility, satisfaction, and
cost estimates.
Results FOCUS had positive effects on QOL (p = .014), emo-
tional (p = .012), and functional (p = .049) well-being, emo-
tional distress (p = .002), benefits of illness (p = .013), and
self-efficacy (p = .001). Intervention fidelity was 85% with
enrollment and retention rates of 71.4 and 90%, respectively.
Participants were highly satisfied. Cost for oversight and de-
livery of the five-session FOCUS program was $168.00 per
dyad.
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Conclusions FOCUS is an economic and effective interven-
tion to decrease distress and improve the quality of life for
dyads.
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Introduction
Although cancer patients receive state-of-the-art medical care,
they seldom have help coping with the detrimental effects of
the illness on their quality of life (QOL) [1]. Family caregivers
provide complex care in the home with little support, which
reduces caregivers’ self-efficacy and increases their distress
[2]. Although interventions have been developed to support
cancer patients and their family caregivers, they seldom move
from efficacy testing to implementation in community settings
where people can benefit from them [3].
The FOCUS prog ram is an ev idence -based ,
psychoeducational intervention that improves patient and care-
giver outcomes (e.g., emotional distress, QOL) as demonstrated
in three randomized clinical trials (N = 947 patient-caregiver
pairs) [4–6]. We piloted implementation of FOCUS in one local
Cancer Support Community (CSC) site with demonstrated effec-
tiveness when implemented by agency social workers using a
small group format [7]. The purpose of this studywas to examine
program outcomes, feasibility, and satisfaction with implementa-
tion of FOCUS in two CSC sites outside our local community.
We also examined costs of delivering the FOCUSprogramwhich
has not been evaluated previously.
Study aims were as follows:
1. To determine effects of the FOCUS program on patient-
caregiver dyad’s primary outcomes (emotional distress
and quality of life) and secondary outcomes (benefits of
illness, self-efficacy, dyadic communication) at CSC sites
in Ohio and California
2. To assess the feasibility of program implementation at
these CSC sites
3. To evaluate program satisfaction
4. To estimate costs of delivering FOCUS
Stress-coping theory [8, 9] is an important framework for
understanding how patients and caregivers cope with cancer.
According to the theory, a series of personal, social, and
illness-related factors influence how patients’ and caregivers’
appraise the illness and cope with demands associated with it.
Figure 1 illustrates the stress-coping model as it applies to the
FOCUS Program and the potential intervention effects exam-
ined in this study. The program provides patients and care-
givers with information and support jointly (as unit of care),
which helps increase positive appraisal of the illness (i.e.,
benefits of illness/caregiving), enhance coping resources
(i.e., self-efficacy), improve quality of life, and reduce emo-
tional distress.
Methods
Study design
The study was approved by the University of Michigan
Institutional Review Board. A pre-post-intervention design
(no control group) was used. Primary and secondary outcomes
were completed at baseline (time 1) prior to the intervention
and again 5 weeks later (time 2), following program comple-
tion. A control group was not used because three prior ran-
domized controlled trials demonstrated the efficacy of the
FOCUS program with significant findings across studies
[4–6, 10].
Sites
FOCUSwas implemented at the CSC in Cincinnati, Ohio, and
in SantaMonica, California, each serving approximately 1500
patients annually. The CSC is a large network of community
agencies in the US that provides professional psychosocial
care in a group format at no cost to cancer patients and their
family caregivers. The racial mix at the Cincinnati CSC is
principally Caucasian (81%) and African-American (11%)
whereas the racial mix at the Santa Monica CSC site is
Caucasian (69%), Asian (11%), and Hispanic (7%).
Participants
Patient eligibility criteria were (1) age 18 or older; (2) diagno-
sis of any cancer type including advanced cancer, currently in
treatment or completed treatment in the past 18 months; (3)
physically and mentally able to participate as determined by
the intake licensed therapist; (4) able to read and speak
English; and (5) have a family caregiver willing to participate
in the program. Caregiver eligibility criteria were (1) age 18 or
older, (2) physically and mentally able to participate, (3) able
to speak and read English, (4) identified by the patient as the
primary caregiver, and (5) willing to participate in the study.
Family caregiver was defined as an individual who provided
emotional and/or physical support to the patient, without pay.
Caregivers were excluded if they were diagnosed with cancer
in the previous year or were receiving active treatment for
cancer so all dyads were managing the effects of cancer in
the patient, not the caregiver. A sample size of 56 dyads was
planned to provide 80% power [11, 12] to detect a medium
effect size (d = .37) with alpha of .05 two tailed, based on the
effects from our prior implementation study [7].
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The FOCUS intervention
FOCUS is a psychoeducational intervention delivered to
patient-caregiver pairs (dyads) that addresses Family involve-
ment, Optimistic attitude, Coping effectiveness, Uncertainty
reduction, and Symptom management (see Table 1) [13]. The
program was delivered by a master’s prepared facilitator (li-
censed social worker, family therapist) employed by each of
the CSC sites, in a group format of three to four dyads (6–8
people), and was comprised of five weekly face-to-face ses-
sions of 2 hours each. Eleven five-session FOCUS programs
were delivered over 12 months.
Implementation strategies
Implementation was guided by the Translating Research into
Practice Model in which implementation is promoted through
communication among program developers and program facil-
itators [14–16]. Thus, an Implementation Training Manual and
a FOCUS Intervention Protocol Manual were developed. The
training manual was designed to educate CSC program direc-
tors and facilitators about the efficacy of FOCUS, program
components, resources for implementation, and the research
components (e.g., informed consent). The FOCUS
Intervention Protocol Manual was designed for use by the fa-
cilitator to foster delivery and documentation of fidelity to the
weekly FOCUS activities. A 1-day training program was held
for CSC site program directors and facilitators (see Table 2).
Other implementation strategies included (1) providing sets of
pre-packagedmaterials to implement each 5-week FOCUS pro-
gram, (2) weekly conference calls with facilitators to provide
guidance on issues that arose, and (3) teleconference attendance
of the facilitators at monthly investigator team meetings.
Instruments
Primary outcomes
Emotional distress was measured using the Cancer
Support Source Distress Scale (CSSDS) developed by the
Cancer Support Community [17]. Reliability and validity
have been demonstrated [17]. Quality of life was mea-
sured using the Functional Assessment of Cancer
Treatment-General (FACT-G) QOL Scale (version 4) [18].
The FACT-G has demonstrated validity, and both the orig-
inal and modified versions have demonstrated reliability in
cancer patients and their caregivers [5–7] (see Table 3).
Secondary outcomes
The Benefits of Illness Scale [20] was used to measure
patients’ and caregivers’ perceived benefits arising from
the cancer illness (e.g., led me to be more accepting of
things). Validity and reliability have been demonstrated
[20]. The Lewis’ Cancer Self-efficacy Scale (CASE) was
used to measure confidence to manage cancer [21].
Validity and reliability have been demonstrated in mul-
tiple studies [5, 6, 21]. The Lewis’ Mutuality and
Interpersonal Sensitivity Scale (MIS) was used to mea-
sure communication between the patient and caregiver
about cancer [21]. Validity and reliability have been
demonstrated in multiple studies [6, 7, 21] (see
Table 3). Demographic questions assessed participants’
age, gender, marital status, race, education, income, and
employment status. Medical-related questions assessed
patients’ type and stage of cancer, and whether they
were currently receiving treatment.
Feasibility
Feasibility was measured by (1) enrollment and retention rates
and (2) intervention fidelity. Data regarding fidelity to the
FOCUS program was collected through the fidelity checklist
in the FOCUS protocol manual, completed by the facilitator,
for activities to be done during each of the five sessions.
Activities to complete across the five sessions were 104 (ses-
sion 1 = 25; session 2 = 17; session 3 = 18; session 4 = 19;
session 5 = 25).
• Emoonal distress
• Quality of life
FOCUS Program
• Community
implementaon
• Two CSC sites
INTERVENTION PRIMARY OUTCOMES
SECONDARY OUTCOMES
Appraisal
• Benefits of illness or caregiving
Coping Resources
• Self-efficacy
• Dyadic communicaon
Key:
Potenal intervenon effects
Theorecal path (not tested)
Fig. 1 Theoretical framework:
stress-coping model
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Satisfaction
Satisfaction was measured by the FOCUS Satisfaction
Instrument [7]. It includes seven items for rating satisfaction
with components of the program (1 = not satisfied to 5 = very
satisfied); ratings are summed and divided by seven to arrive
at overall satisfaction scores. It includes open-ended questions
regarding session lengths and FOCUS program length.
Program costs
Program costs were calculated by multiplying hourly time
estimates and median hourly wages for healthcare social
workers in California and Ohio according to the US Bureau
of Labor Statistics, May 2015 (CA: $32.53; OH: $26.01).
Costs were estimated for the average total cost to deliver one
five-session FOCUS program at each site and across sites.
Table 2 Outline of the training
program for CSC sites Topic Presenter/facilitator Time allocation
Welcome and introductions M. Titler 30 min
Implementation of evidence-based programs: overview M. Titler 15 min
FOCUS program
• History, development and testing
• Core components: F-O-C-U-S
• Implementation in CSC
• Project aims
• Expectations
• Timeline for this project
L. Northouse 45 min
Pre-implementation-
• Roles and responsibilities of
○ CSC program director,
○ Group facilitator
• Interagency communication
• Marketing materials
• Recruitment and retention
B. Dockham 60 min
Implementation
• Intake screening and eligibility
• FOCUS Intervention Protocol Manual
• Educational materials
• Dyad binder for materials
• FOCUS intervention fidelity—checklist
• Participant commitment
• Building groups and group dynamics
• Overcoming potential barriers
• Training video, case scenarios and discussion
B. Dockham with
L. Northouse
A. Schafenacker
M. Visovatti
135 min
Research component
• Obtaining consent
• Use of coding and tracking log
• Questionnaires for patient and caregiver
• Data collection procedures
• Baseline and follow-up packets for patient and caregiver
• Data for cost analysis
• Data storage and security
• Procedures for returning questionnaires and other data to UM
• Potential adverse events and reporting
• Monthly teleconference with investigative team
L. Northouse
M. Visovatti
M. Titler
B. Dockham
90 min
Further discussion and wrap-up All 30 min
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Time estimates Preparation and wrap-up time for each of the
five sessions were estimated as 20 min based on our previous
study [7]. Facilitators at each of the two CSC sites logged the
session time in minutes at the end of each session on the
fidelity checklist. We summed across all 11 FOCUS
Programs, (1) the logged session times and (2) the preparation
and wrap-up times to arrive at the total time to deliver
FOCUS; this was then divided by 11 (number of programs
delivered) to arrive at the mean time to deliver a five-session
FOCUS program. The mean total time across both sites to
deliver FOCUS including preparation and wrap-up was
11.2 h (SD =0.3). We also accounted for estimated time for
program oversight. These estimates per FOCUS program are
based on our prior study as follows [7]: marketing—1.5 h;
recruiting and outreach—1 h; intake and screening for eligi-
bility—7 h; and organization of education materials—1.5 h.
These oversight estimates (11 h) were added to the mean time
to deliver a five-session FOCUS program (11.2 h), as de-
scribed above, resulting in an estimated 22.2 h to provide
oversight and delivery of one five-session FOCUS program.
Cost estimates To calculate cost estimates, the time to provide
oversight and delivery of FOCUS (22.2 h) was multiplied by
the median hourly wage for each respective site, resulting in
site specific cost estimates. The average cost across sites to
provide oversight and deliver one FOCUS program was cal-
culated by multiplying the site specific costs by the number of
FOCUS programs delivered at each site. These values were
then summed and divided by 11, the number of FOCUS pro-
grams delivered across sites.
Data collection procedures
Patient and caregiver versions of the baseline (time 1) ques-
tionnaires consisting of Cancer Support Source Distress Scale,
FACT-G QOL Scale, Benefits of Illness Scale, Lewis’ Cancer
Self-Efficacy Scale, Lewis’ Mutuality and Interpersonal
Sensitivity Scale (see Table 3), and demographic and
medical-related questions were completed prior to beginning
the FOCUS program. Questionnaires were mailed or given to
participants during the intake visit and collected immediately
prior to the first FOCUS program session. Patients and care-
givers completed questionnaires independently. Follow-up
questionnaires (time 2) included the major scales, noted
above, and the Focus Satisfaction Instrument, and were ad-
ministered immediately after the last FOCUS session.
Data analysis
For aim 1, repeated measures analysis of variance was used
to determine if changes occurred in primary and secondary
outcomes from time 1 to time 2 for patients and caregivers
as dyads (i.e., pairs). Dyadic analysis was used because
patients’ and caregivers’ responses to illness are interrelated
[22, 23]. Time and role (patient vs. caregiver) were treated
as within-subject variables to control for the interdependent
nature of the data. Main effect by time was examined to
determine the overall effectiveness of the FOCUS interven-
tion on primary and secondary outcomes for patient-
caregiver dyads as a unit. Time-by-role interactions were
analyzed to determine if there was a differential effect of
the intervention on patients’ and caregivers’ outcomes.
Table 3 Primary and secondary outcome measures
Instrument name Description Scoring and interpretation
Cancer Support Source
Distress Scale [17]
Consists of 15 items to measure the extent of concern
(0 = not at all to 5 = very seriously) about various
emotions related to the cancer experience
Score of 0 to 60 is calculated by summing ratings
across all items. Higher scores indicate greater
emotional distress
FACT-G (version 4) [18] Consists of 27 items to measure overall QOL, and the
domains for physical, social, emotional, and functional
well-being in cancer patients (0 = not at all to 4 = very
much). For caregivers, FACT-G was slightly modified
using nearly identical items [19]
QOL score of 0–108 is calculated by summing
item ratings across all domains. Domain scores
are calculated by summing individual items
within the domain. Higher scores indicate higher
well-being (subscales) and QOL
Benefits of Illness Scale [20] Consists of 11 items to measure patients and caregivers
perceived benefits (1 = not at all to 4 = a lot) arising
from the cancer illness
Score of 1 to 4 is calculated by summing ratings on
all items and dividing by 11. Higher scores
indicate more perceived benefits of illness
Lewis’ Cancer Self-efficacy Scale [21] Consists of 17 items to measure patients’ and caregivers
confidence to manage cancer (0 = not at all to
10 = very confident)
Score of 0 to 170 is calculated by summing ratings
across all items. Higher scores reflect higher
self-efficacy
Lewis’ Mutuality and Interpersonal
Sensitivity Scale [21]
Consists of 23 items to measure dyadic communication
about cancer (1 = never true to 5 = always true)
Score of 1 to 5 is calculated by summing ratings
across all items and dividing by 23. Higher
scores indicate more perceived open
communication between the patient and
caregiver about cancer
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Cancer stage was used as a control variable in the main
effect analysis (effect of intervention on outcome) and in-
teraction effect analysis (differential effect of intervention
on patients’ and caregivers’ outcomes) for physical and
functional well-being because significant associations
(p < 0.05) were found between cancer stage and these
outcomes for patients (F = 3.46 for physical; F = 2.83
for functional). Intervention effect sizes were examined
for specific variables based on conventional standards
(small = 0.20; medium = 0.50; large = 0.80) [11].
Descriptive statistics were used to examine enroll-
ment and retention rates and intervention fidelity (aim
2). The enrollment rate was calculated by the number of
dyads enrolled in the FOCUS program divided by the
number eligible to participate. The retention rate was
calculated by the number of dyads who completed the
FOCUS program divided by the number who enrolled.
For intervention fidelity, there were 104 total activities
to complete across the five sessions per FOCUS pro-
gram, and a total of 11 FOCUS programs were deliv-
ered. Fidelity for the FOCUS program was calculated
by summing the number of activities documented as
provided across all sessions for the 11 FOCUS pro-
grams delivered divided by total activities possible by
programs (104 × 11). This resulted in a mean fidelity
for the FOCUS program which had been delivered 11
times.
Descriptive statistics were used to examine patients’ and
caregivers’ total satisfaction scores (aim 3) with follow-up
exploratory analyses using paired t tests to examine
differences in patients’ and caregivers’ scores. Calculation of
estimated program costs is described above.
Results
Participant characteristics
The final sample was 36 dyads (see Fig. 2). Patients’mean age
was 60.8 and caregivers’was 55.9 (see Table 4). The majority
of participants were female (patients, 52.8; caregivers, 55.6),
and most were married or partnered (>85%). The sample was
largely white, with a moderate income. Most were well edu-
cated with a college education or higher. Most patients had
stage II or IV cancer and were currently in treatment (69.4%).
Effectiveness of the FOCUS program intervention
The FOCUS program was effective (see Table 5). The inter-
vention had significant positive effects on dyads’ primary out-
comes of total QOL (p = .014), emotional (p = .012) and
functional (p = .049) well-being, and emotional distress
(p = .002). The intervention did not have significant effects
on physical and social well-being. The intervention had sig-
nificant positive effects on the dyads’ secondary outcomes of
benefits of illness (p = .013) and self-efficacy (p = .001) but
not on dyadic communication regarding cancer. Reliability of
instruments in this study was high (see Table 5).
Enrollment rate
71.4%    →  
Retenon rate
90%   → 
Dyads referred
N = 89 dyads
Completed Time 1
Baseline
N = 40 dyads
Completed Time 2
N = 36 dyads
Ineligible (n=33)
No response, did not return call (20)
Died (8)
Too far out of treatment (2)
Lives too far away (2)
No caregiver (1)
Arion (n = 4)
Reasons:
Paent went to hospice (2)
Unfavorable group dynamics (2)
Eligible dyads
N = 56 Declined study (n= 16)
Changed mind/not interested (9)
Too sick (3)
Cannot commit (2)
Schedule conflict (1)
Caregiver unable to aend (1)
Fig. 2 FOCUS CSC consort
diagram final N = 36 dyads
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Table 4 Demographic and medical characteristics of sample
Characteristics Patients (n = 36) Caregivers (n = 36)
Mean SD Range Mean SD Range
Age 60.8 14.2 18–88 55.9 15.1 19–83
n % n %
Gender Male 17 47.2 16 44.4
Female 19 52.8 20 55.6
Marital status Married/partnered 32 88.9 31 86.1
Single 3 8.3 5 13.9
Divorced 1 2.8
Race White 32 88.9 28 77.8
Asian 1 2.8 3 8.3
Black or African-American 1 2.8 1 2.8
Latino or Hispanic 1 2.8 1 2.8
Other 1 2.8 1 2.8
Missing 2 5.5
Education Less than high school 2 5.6
High school grad or GED 1 2.8 1 2.8
Some college, technical or vocational school 6 16.7 7 19.4
College graduate 7 19.4 14 38.9
Some graduate school 3 8.3 1 2.8
Graduate degree 17 47.2 12 33.3
Prefer not to share 1 2.8
Income Less than $39,999 3 8.3 1 2.8
$40,000–$99,999 14 38.9 14 38.9
$100,000 or above 16 44.4 15 41.7
Missing 3 8.3 5 13.9
Employment Full time 5 13.9 17 47.2
Part time 5 13.9 2 5.6
Not employed 9 25.0 5 13.9
Retired 13 36.1 9 25.0
Disabled 4 11.1
Student 1 2.8
Missing 2 5.6
Type of cancer Breast 6 16.7
Pancreatic 4 11.1
Gynecologic 4 11.1
Prostate 4 11.1
Brain 3 8.3
Lung 3 8.3
Lymphoma 3 8.3
Multiple myeloma 2 5.6
Colorectal/GI 2 5.6
Kidney/adrenal 2 5.6
Nose/throat 2 5.6
Skin (non-melanoma) 1 2.8
Stage of cancer I 6 16.7
II 8 22.2
III 6 16.7
IV 13 36.1
Unknown 2 5.6
Missing 1 2.8
Currently in treatment Yes 25 69.4
No 10 27.8
Missing 1 2.8
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Feasibility
As displayed in Fig. 2, the enrollment rate was 71.4% and the
retention rate was 90%. Intervention fidelity was 85%.
Satisfaction
Caregivers and patients reported high satisfaction, and scores
did not differ significantly [(patients: 4.4 (SD 0.6); caregivers:
4.5 (SD 0.5)]. The majority of patients (86.1%) and caregivers
(80.6%) reported the program helped them cope with cancer.
Most reported that the program did not duplicate services pro-
vided at their treatment center (85.3% each). When asked
about the length of each session (about right; shorter; longer),
the majority of patients (86.1%) and caregivers (80.6%) noted
the session lengths were about right. When asked about the
number of group sessions (about right, fewer, more), 52.8% of
the patients and 50% of the caregivers wanted more; 47.2%
noted the number was about right. Over 90% of patients and
caregivers noted they would recommend the program to
others facing cancer.
Estimated program costs
Due to differing geographic hourly wage rates, California es-
timated costs ($722.17) were higher than Ohio ($577.42).
Average cost estimates for oversight and delivery of one
five-session FOCUS program was $669.45 or $168.00 per
dyad, assuming four dyads per group.
Discussion
Program effectiveness
The FOCUS program was effective in improving the primary
outcomes of quality of life, emotional and functional well-
being, and emotional distress. This is consistent with other
couple-based group interventions for cancer patients and their
Table 5 Effectiveness of the FOCUS program intervention (N = 36 dyads)
Mean (SD) p values Effect sizesb
Patient Caregiver Main effect Interaction effect Patient Caregiver Dyad
Outcomes Reliabilitiesa Time 1 Time 2 Time 1 Time 2 Time* Role by time** d d d
Quality of life
Total QOL .92; .86 67.24
(17.40)
71.52
(16.91)
72.59
(11.97)
76.11
(15.72)
.014 .826 0.249 0.252 0.309
Physical .84; .73 17.67
(5.47)
18.58
(6.38)
24.29
(2.72)
23.75
(4.86)
.986 .412 0.153 0.137 0.030
Social .84; .71 18.15
(5.85)
19.51
(5.37)
18.08
(4.98)
18.77
(5.11)
.061 .392 0.242 0.136 0.214
Emotional .86; .83 14.92
(5.97)
16.42
(5.04)
13.53
(4.40)
14.64
(5.59)
.012 .695 0.272 0.221 0.341
Functional .79; .84 16.51
(4.89)
17.01
(5.15)
16.57
(4.59)
18.95
(5.34)
.049 .520 0.010 0.477 0.400
Benefits of illness .88; .92 2.88
(.65)
2.97
(.61)
2.80
(.65)
2.98
(.77)
.013 .731 0.143 0.253 0.264
Communication .96; .96 3.52
(.91)
3.62
(.75)
3.49
(.80)
3.64
(.77)
.075 .321 0.120 0.191 0.186
Emotional distress .89; .90 22.61 (11.67) 18.31
(9.38)
20.86
(9.59)
18.58
(10.58)
.002 .236 0.406 0.226 0.411
Self-efficacy .96; .97 113.97 (32.43) 119.11
(29.35)
105.08
(32.31)
122.47
(32.23)
.001 .052 0.166 0.517 0.512
a Reliabilities are the average across time points for patients and caregivers
b Absolute value of effect size (Cohen’s d) d = (mean1 − mean 2)/s where s = pooled standard deviation
*Significance (p value) of main effect by time: does the outcome change from time 1 to time 2 for the dyad; significant findings (p < .05) are italicized
**Significance (p value) of interaction effect of role by time: does the amount of change from time 1 to time 2 differ for patients and caregivers; no
significant findings (p > .05)
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partners [24]. In qualitative statements, patients and caregivers
reported that it was very helpful to have their partner or care-
giver attend the group intervention with them. Both patients
and caregivers were able to express feelings and learn from
others, and this opportunity may have helped improve their
QOL and emotional distress. FOCUS also was effective in
improving perceived benefits of experiencing cancer (benefits
of illness) and level of confidence in managing it (self-effica-
cy). Prior research with cancer patients and caregivers has
demonstrated that group interventions facilitate positive reap-
praisal of the illness [25] and can increase caregivers’ pre-
paredness and competence to provide care [26]. The findings
and effect sizes obtained for the domains of QOL, benefits of
illness, and self-efficacy in this study are similar to those ob-
tained in our prior randomized trials when FOCUS was deliv-
ered by a nurse to individual dyads at home [4–6, 27] and in
our previous implementation study [7]. The magnitude of the
intervention effects in this study are similar to small-medium
effect sizes reported in three meta-analyses examining inter-
vention effects with patients and caregivers across multiple
studies [3, 28, 29].
Participants’ physical well-being, social well-being, and
dyadic communication did not improve. The lack of improve-
ment in physical well-being (e.g., nausea, pain) is not surpris-
ing because FOCUS is a psychoeducational intervention and
improvements in physical well-being require tailored inter-
ventions that address the biological components of cancer.
However, there was an improvement in functional well-
being (e.g., ability to work; enjoy life). Perhaps, participants
learned how to address physical challenges and related symp-
toms so that they could function in their daily lives. The lack
of improvement in social well-being may be due to higher
baseline social well-being scores with less room for improve-
ment. Lack of improvement in dyadic communication is dif-
ficult to explain. FOCUS may have stimulated beginning
communication about cancer that did not carry over into par-
ticipants’ daily lives. Additional work regarding how commu-
nication is conceptualized and measured as an outcome of
FOCUS may be warranted in future studies (i.e., qualitative
approach with participants).
Feasibility
It is feasible to deliver FOCUS in a group format in CSC sites.
Enrollment rates were good (71.4%) and higher than those
reported in other studies using group interventions with
patient-caregiver dyads (10.4%) [24] or family caregivers
(25–31%) [30, 31]. Perhaps this is because agency staff re-
cruited participants and delivered the intervention. Retention
rates (90%) were high most likely because of perceived ben-
efits from the group and its dyadic approach.
FOCUS was delivered with high intervention fidelity
(85%) and was similar to a couple-focused group intervention
with breast cancer patients (88%) [24]. The implementation
strategies were important for providing initial and ongoing
support to the group facilitators and helped maintain high
intervention fidelity.
Satisfaction
Participants were highly satisfied with the FOCUS program
and the overwhelming majority would recommend the pro-
gram to others. About half of the participants wanted more
sessions, raising the issue of optimal intervention dose. In our
prior implementation study, using a six-session group inter-
vention, >40% of the participants also reported they would
have liked more sessions [7]. One challenge in planning an
intervention is balance between feasibility (i.e., enrollment,
retention) and outcomes (i.e., program effectiveness). Manne
et al. [24] found a low enrollment rate (10.4%) among cancer
patients who were approached for an 8-week group interven-
tion, with 15.7% expressing worry about the program length.
Bultz et al. [30] found low enrollment (31%) for a 6-week
group intervention for partners, with 29% stating time was
an issue. Determining optimal intervention dose needs further
exploration.
Program cost
This study provided the first cost estimate of delivering the
five-session FOCUS program; about $168.00 per dyad.
Badger et al. [32] estimated costs of their 8-week dyadic tele-
phone intervention as $164.68 per dyad but omitted oversight
and preparation costs included in our estimates. Given the
skyrocketing healthcare costs in the US, FOCUS is highly
economical to address critical issues of those living with
cancer.
Limitations
One limitation is enrollment of 36 rather than 56 dyads as
planned. Despite this limitation, the dyadic effects for many
variables were >0.30, and we were able to demonstrate the
effectiveness of the FOCUS program. Performing cost-
effective analyses was not a study aim and requires use of a
control group which deprives patients and caregivers from an
intervention that has demonstrated efficacy and effectiveness.
We did, however, provide a cost estimate for delivery of
FOCUS in CSCs.
Conclusions
FOCUS delivered in a group, dyadic format is an economi-
cally feasible intervention that decreases emotional distress
and improves quality of life, perceived benefits from
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experiencing cancer, and confidence in managing it. It is time
that programs like FOCUS receive national public policy at-
tention to effect payment structures for delivery to cancer pa-
tients and their caregivers.
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